![E. Sutherland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
E. Sutherland
Chief Executive Officer at
UPSTREAM BIO, INC.
Net worth: 490 019 $ as of 2026-06-29
Profile
E.
Rand Sutherland is Chief Executive Officer & Director at Upstream Bio, Inc. since 2024.
Dr. Sutherland is Independent Director at Krystal Biotech, Inc. since 2022.
Dr. Sutherland is Independent Director at Vanqua Bio, Inc. since 2022.
Formerly, Dr. Sutherland was Chief Executive Officer at Seeker Biologics, Inc. from 2022 to 2023.
Dr. Sutherland was Independent Director at Allakos, Inc. from 2023 to 2024.
Dr. Sutherland was President at Translate Bio, Inc. in 2021.
Dr. Sutherland was Professor at The University of Colorado.
Dr. Sutherland was Chief of Pulmonary at National Jewish Health, Inc. Dr. Sutherland was SVP & Global Head-Medical Affairs at Genzyme Therapeutics Ltd. from 2018 to 2021.
Education includes undergraduate degree from Oberlin College, doctorate from The University of Chicago, and graduate degree from Harvard T.H.
Chan School of Public Health.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
UPSTREAM BIO, INC. 0.13% | 2026-06-15 | 70,812 ( 0.13% ) | 490 019 $ | 2026-06-29 |
| 2026-03-22 | 0 ( -.--% ) | - $ | 2026-06-29 |
E. Sutherland active positions
| Companies | Position | Start |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Director/Board Member | 2022-01-17 |
| UPSTREAM BIO, INC. | Chief Executive Officer | 2024-04-01 |
Vanqua Bio, Inc.
 Vanqua Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that focused on developing novel therapies for Parkinson's disease | Director/Board Member | 2022-07-31 |
Former positions of E. Sutherland
| Companies | Position | End |
|---|---|---|
| ALLAKOS INC. | Director/Board Member | 2024-04-30 |
Seeker Biologics, Inc.
 Seeker Biologics, Inc. BiotechnologyHealth Technology Develops immunological therapeutic drugs | Chief Executive Officer | 2023-05-31 |
| TRANSLATE BIO, INC. | President | 2021-09-13 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Chief Tech/Sci/R&D Officer | 2021-02-28 |
National Jewish Health, Inc.
 National Jewish Health, Inc. Medical/Nursing ServicesHealth Services Provides treatment of and conducts research in respiratory, immune and allergic disorders | Corporate Officer/Principal | - |
Training of E. Sutherland
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
12
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Oberlin College
 Oberlin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Harvard T.H. Chan School of Public Health
 Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Jewish Health, Inc.
National Jewish Health, Inc. Medical/Nursing ServicesHealth Services Provides treatment of and conducts research in respiratory, immune and allergic disorders | Health Services |
Allakos, Inc.
 Allakos, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases | Health Technology |
Krystal Biotech, Inc.
 Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Vanqua Bio, Inc.
Vanqua Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company that focused on developing novel therapies for Parkinson's disease | Commercial Services |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
Seeker Biologics, Inc.
Seeker Biologics, Inc. BiotechnologyHealth Technology Develops immunological therapeutic drugs | Health Technology |
- Stock Market
- Insiders
- E. Sutherland
